AU1159897A - Analogs of peptide yy and uses thereof - Google Patents

Analogs of peptide yy and uses thereof

Info

Publication number
AU1159897A
AU1159897A AU11598/97A AU1159897A AU1159897A AU 1159897 A AU1159897 A AU 1159897A AU 11598/97 A AU11598/97 A AU 11598/97A AU 1159897 A AU1159897 A AU 1159897A AU 1159897 A AU1159897 A AU 1159897A
Authority
AU
Australia
Prior art keywords
analogs
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11598/97A
Other languages
English (en)
Inventor
Ambikaipakan Balasubramaniam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CINCINNATI THE, University of
Original Assignee
CINCINNATI THE, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CINCINNATI THE, University of filed Critical CINCINNATI THE, University of
Publication of AU1159897A publication Critical patent/AU1159897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU11598/97A 1996-11-13 1996-11-13 Analogs of peptide yy and uses thereof Abandoned AU1159897A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/018374 WO1998020885A1 (fr) 1996-11-13 1996-11-13 Analogues de peptide yy et leurs utilisations

Publications (1)

Publication Number Publication Date
AU1159897A true AU1159897A (en) 1998-06-03

Family

ID=22256144

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11598/97A Abandoned AU1159897A (en) 1996-11-13 1996-11-13 Analogs of peptide yy and uses thereof

Country Status (5)

Country Link
EP (1) EP1015007A1 (fr)
JP (1) JP2000505105A (fr)
AU (1) AU1159897A (fr)
CA (1) CA2271788A1 (fr)
WO (1) WO1998020885A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
EP1189629B1 (fr) * 1999-02-10 2010-09-29 Curis, Inc. Peptide yy (pyy) pour traiter des troubles metaboliques du glucose
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
MXPA04002751A (es) 2001-09-24 2005-09-08 Univ Oregon Health & Science Modificacion del comportamiento de alimentacion.
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
EA008829B1 (ru) 2002-12-17 2007-08-31 Нэстек Фармасьютикал Кампани Инк. Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения
US7229966B2 (en) 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7811989B2 (en) 2003-01-17 2010-10-12 Ipsen Pharma S.A.S. Peptide YY analogs
EP1789440A4 (fr) * 2004-02-11 2008-03-12 Amylin Pharmaceuticals Inc Motifs de la famille de polypeptides pancreatiques et polypeptides les renfermant
NZ551196A (en) 2004-05-14 2010-08-27 Emisphere Tech Inc Compounds and compositions for delivering active agents
JP4995080B2 (ja) 2004-05-14 2012-08-08 エミスフェアー・テクノロジーズ・インク 活性薬剤を送達するためのアリールケトン化合物および組成物
NZ555533A (en) 2004-12-13 2010-03-26 Amylin Pharmaceuticals Inc Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
JP2009504681A (ja) 2005-08-11 2009-02-05 アミリン・ファーマシューティカルズ，インコーポレイテッド 選択可能な特性を有するハイブリッドポリペプチド
TWI428346B (zh) 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
PT2651398T (pt) 2010-12-16 2018-03-09 Novo Nordisk As Composições sólidas compreendendo um agonista de glp-1 e um sal de ácido n-(8-(2-hidroxibenzoil)amino) caprílico
HUE062740T2 (hu) 2012-03-22 2023-12-28 Novo Nordisk As GLP-1 peptidek készítményei és elõállításuk
EP3068795B1 (fr) 2013-11-15 2019-03-06 Novo Nordisk A/S Beta-homo arginine substitution au position 35 de hpyy(1-36)
SI3068421T1 (sl) 2013-11-15 2019-08-30 Novo Nordisk A/S Selektivne spojine PYY in njihova uporaba
BR112017025108A2 (pt) 2015-06-12 2018-07-31 Novo Nordisk As compostos seletivos de pyy e usos dos mesmos
BR112020014624A2 (pt) 2018-02-02 2020-12-08 Novo Nordisk A/S Composições sólidas compreendendo agonista de glp-1, sal de ácido n-(8-(2-hidroxibenzoil) amino)caprílico e lubrificante

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026685A (en) * 1988-07-15 1991-06-25 The Salk Institute For Biological Studies NPY peptide analogs
US5328899A (en) * 1988-07-15 1994-07-12 The Salk Institute For Biological Studies NPY peptide analogs

Also Published As

Publication number Publication date
JP2000505105A (ja) 2000-04-25
WO1998020885A1 (fr) 1998-05-22
CA2271788A1 (fr) 1998-05-22
EP1015007A1 (fr) 2000-07-05

Similar Documents

Publication Publication Date Title
HU9502833D0 (en) Analogs of peptide yy and uses thereof
AU6360394A (en) Vasonatrin peptide and analogs thereof
AU1159897A (en) Analogs of peptide yy and uses thereof
AU4230196A (en) Treatment of pancreatic tumors with peptide yy and analogs thereof
AU692612B2 (en) Peptide mixture and products thereof
AU3574897A (en) Aqueous formulations of peptides
EP0880356A4 (fr) Peptides antimicrobiens et procedes d'utilisation associes
IL128529A0 (en) Anti-inflammatory peptides and uses thereof
AU5893696A (en) Modification of polypeptides
EP0785276A4 (fr) Modification d'un peptide et d'une proteine
AU2548097A (en) Formulations of ob protein
AU1884397A (en) Antifungic and antibacterial peptide
AU2526497A (en) Post-labeling stabilization of radiolabeled proteins and peptides
AU4463996A (en) Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU5893796A (en) Modification of polypeptides
AU2972097A (en) Peptide derivatives
AU1731997A (en) Antipathogenic peptides and compositions comprising them
AU2091799A (en) Uses of alpha-conotoxin peptides
AU4427296A (en) Novel peptide
AU1803597A (en) Peptide derivatives
AU4905497A (en) Antimicrobial peptide analogs of gramicidin s and compositions comprising them
AU4074997A (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
AU2054797A (en) Isolated human herpesvirus type 8 sequences and uses thereof
AU3118297A (en) Sok-1 and methods of use
AU4236097A (en) Mhc peptides and methods of use